Get the latest Science News and Discoveries

Semaglutide: A Diet Drug Dilemma for Medicare With a $145 Billion Price Tag

A significant proportion of Medicare beneficiaries may qualify for the weight loss medication semaglutide, dependent on cardiovascular health criteria. Costs could range from $10 billion to $145 billion annually, based on how broadly cardiovascular disease is defined, highlighting a critical deci

None

Get the Android app